← All trials
NCT02985671
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2017
- Primary completion
- Aug 1, 2018
- Completion date
- Oct 1, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 110
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Ache Laboratorios Farmaceuticos S.A.Lead sponsor
- Association of Assistance to the Disabled ChildOverall official - principal investigator
- Center for the Development of Clinical Studies BrazilOverall official - principal investigator
- Allergisa Pesquisa Dermato-Cosmetica LTDAOverall official - principal investigator
- Instituto Nacional de Traumatologia e OrtopediaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.